{"prompt": "['Protocol Identifying Number: PS-001', 'Protocol Version: 1.0', 'Protocol Date: 10 Sep 2017', '34. Gu L, Lau SK, Loera S, Somlo G, Kane SE. Protein kinase A activation confers resistance to', 'trastuzumab in human breast cancer cell lines. Clin Cancer Res. 2009; 15:7196-206.', '35. Cole SW, Sood AK. Molecular pathways: beta-adrenergic signaling in cancer. Clin Cancer Res.', '2012; 18:1201-6.', '36. Lutgendorf SK, Degeest K, Dahmoush L, et al. Social isolation is associated with elevated tumor', 'norepinephrine in ovarian carcinoma patients. Brain Behav Immun. 2011; 25:250-5.', '37. Lutgendorf SK, Degeest K, Sung CY, Arevalo JM, Penedo F, Lucci J 3rd, et al. Depression, social', 'support, and beta-adrenergic transcription control in human ovarian cancer. Brain Behav', 'mmun. 2009; 23:176-83.', '38. Cole S, Arevalo J, Takahashi R, Sloan EK, Lutgendorf S, Sood AK, et al. Computational', 'identification of gene-social environment interaction at the human IL6 locus. Proc Natl Acad Sci', 'USA. 2010; 107:5681-6.', '39. Sloan EK, Capitanio JP, Tarara RP, Mendoza SP, Mason WA, Cole SW. Social stress enhances', 'sympathetic innervation of primate lymph nodes: mechanisms and implications for viral', 'pathogenesis. J Neurosci. 2007; 27:8857-65.', '40. Mickisch GH, Garin A, van Poppel H, et al. Radical nephrectomy plus interferon-alfa-basec', 'immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a', 'randomized trial. Lancet 2001; 358:966.', '41. Heng DY, Wells JC, Rini BI, et I. Cytoreductive nephrectomy in patients with synchronous', 'metastases from renal cell carcinoma: results from the International Metastatic Renal Cell', 'Carcinoma Database Consortium. Eur Urol. 2014; 66:704-10.', '42. Ljungberg B. The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.', 'Curr Urol Rep 2013; 14:19-25.', '43. Van der Poel HG, Roukema JA, Horenblas S, et al. Metastasectomy in renal cell carcinoma: A', 'multicenter retrospective analysis. Eur Urol 1999; 35(3):197-203.', '44.', 'Negrier S, Escudier B, Lasset C, et al. Recombinant human interleukin-2, recombinant human', 'interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Fran\u00e7ais', \"d'Immunoth\u00e9rapie. N Engl J Med 1998; 338(18):1272-8.\", '45. Greef B, Eisen T. Medical treatment of renal cancer: new horizons. Br J Cancer. 2016; 115:505-', '16.', '46. Motzer RJ, Hutson TE, Tomczak P, et al. Sunitinib versus interferon alfa in metastatic renal-cell', 'carcinoma. N Engl J Med 2007; 356(2):115-24.', '47.', 'Ruiz-Morales JM, Swierkowski M, Wells JC, et al. First-line sunitinib versus pazopanib in', 'metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma', 'Database Consortium. Eur J Cancer. 2016; 65:102-8.', '48. Bracarda S, lacovelli R, Boni L et al. Sunitinib administered on 2/1 schedule in patients with', 'metastatic renal cell carcinoma: the RAINBOW analysis. Ann Oncol. 2015; 26:2107-13.', '49. Lee JL, Kim MK, Park I, et al. RandomizEd phase II trial of Sunitinib four weeks on and two weeks', 'off versus Two weeks on and One week off in metastatic clear-cell type REnal cell carcinoma:', 'RESTORE trial. Ann Oncol. 2015; 26:2300-5.', '50. Hoffmann C, Leitz MR, Oberdorf-Maass S, et al. Comparative pharmacology of human beta-', 'adrenergic receptor subtypes--characterization of stably transfected receptors in CHO cells.', 'Naunyn Schmiedebergs Arch Pharmacol. 2004; 369:151-9.', 'Page 44 of 60']['Protocol Identifying Number: PS-001', 'Protocol Version: 1.0', 'Protocol Date: 10 Sep 2017', '51. Young R1, Glennon RA. S(-)Propranolol as a discriminative stimulus and its comparison to the', 'stimulus effects of cocaine in rats. Psychopharmacology (Berl). 2009; 203:369-82.', '52. Hoyer D, Clarke DE, Fozard JR, et al. International Union of Pharmacology classification of', 'receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev. 1994; 46:157-203.', '53. Available from: https://www.drugs.com/pro/propranolol-tablets.html, accessed on 22 May', '2017.', '54. Shand DG. Pharmacokinetics of propranolol: a review. Postgrad Med J. 1976; 52 Suppl 4:22-25.', '55. Bowman SL, Hudson SA, Simpson G, et al. A comparison of the pharmacokinetics of propranolol', 'in obese and normal volunteers. Br J Clin Pharmacol. 1986; 21:529-32.', '56. Leahey WJ, Neill JD, Varma MPS, et al. Comparison of the efficacy and pharmacokinetics of', 'conventional propranolol and a long acting preparation of propranolol. Br J Clin Pharmacol.', '1980; 9:33-40.', '57. Available from: http://www.mhra.gov.uk/spc-', 'bil/?subsName=PROPRANOLOL%2OHYDROCHLORIDE&pagelD=SecondLevel,accessed on 22 May', '2017.', '58. Coelho M, Moz M, Correia G, et al. Antiproliferative effects of \u00df-blockers on human colorectal', 'cancer cells. Oncol Rep. 2015; 33:2513-20', '59. Schuller HM, Cole B. Regulation of cell proliferation by beta-adrenergic receptors in a human', 'lung adenocarcinoma cell line. Carcinogenesis. 1989; 10:1753-5.', '60. Lin X, Luo K, Lv Z, et al. Beta-adrenoceptor action on pancreatic cancer cell proliferation and', 'tumor growth in mice. Hepatogastroenterology. 2012; 59:584-8.', '61. Bernab\u00e9 DG, Tamae AC, Biasoli \u00c9R, et al. Stress hormones increase cell proliferation and', 'regulates interleukin-6 secretion in human oral squamous cell carcinoma cells. Brain Behav', 'Immun. 2011; 25:574-83.', '62. Valles SL, Benlloch M, Rodriguez ML, et al. Stress hormones promote growth of B16-F10', 'melanoma metastases: an interleukin 6- and glutathione-dependent mechanism. J Transl Med.', '2013; 11:72.', '63. Iseri OD, Sahin FI, Terzi YK, et al. beta-Adrenoreceptor antagonists reduce cancer cell', 'proliferation, invasion, and migration. Pharm Biol. 2014; 52:1374-81.', '64. Lang K, Drell TL 4th, Lindecke A, et al. Induction of a metastatogenic tumor cell type by', 'neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer. 2004;', '112:231-8.', '65. Sood AK, Bhatty R, Kamat AA, et al. Stress hormone-mediated invasion of ovarian cancer cells.', 'Clin Cancer Res. 2006; 12:369-75.', '66. Yang EV, Sood AK, Chen M, et al. Norepinephrine up-regulates the expression of vascular', 'endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal', 'carcinoma tumor cells. Cancer Res. 2006; 66:10357-64.', '67. Guo K, Ma Q, Wang L, et al. Norepinephrine-induced invasion by pancreatic cancer cells is', 'inhibited by propranolol. Oncol Rep. 2009; 22:825-30.', '68. Liao X, Che X, Zhao W, et al. The -adrenoceptor antagonist, propranolol, induces human gastric', 'cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor kB signaling. Oncol Rep.', '2010; 24:1669-76.', 'Page 45 of 60']\n\n###\n\n", "completion": "END"}